glp 1 agonists for type 2 diabetes GLP-1 receptor in the treatment of e Clinical Focus on GLP-1 Agonists
Description
F.LingvayI.et al (2021)
Over 40 weeks, orforglipron patients saw their A1C levels drop by 1.3% to 1.6% , depending on the dosage
2017;25:20 Lu Y, Wu L, Lin M, Bao X, Zhong H, Ke P, et al
Naltrexone/Bupropion ER (Contrave): newly approved treatment option for Chronic Weight Management in obese adults
problems with your gallbladder, kidneys, or pancreas
For example, a medication might strongly activate brain GLP-1 receptors for appetite suppression while only partially activating gut receptors that contribute to nausea
